Seroprevalence of SARS-CoV-2 antibodies in social housing areas in Denmark

被引:10
|
作者
Fogh, Kamille [1 ,2 ,19 ]
Eriksen, Alexandra R. R. [1 ,2 ,19 ]
Hasselbalch, Rasmus B. [1 ,2 ,19 ]
Kristensen, Emilie Sofie [1 ,2 ,19 ]
Bundgaard, Henning [3 ,19 ]
Nielsen, Susanne D. [4 ,19 ]
Jorgensen, Charlotte S. [5 ]
Scharff, Bibi F. S. S. [6 ,19 ]
Erikstrup, Christian [7 ,20 ]
Saekmose, Susanne G. [8 ]
Holm, Dorte K. [9 ,21 ]
Aagaard, Bitten [10 ]
Norsk, Jakob [1 ,2 ,19 ]
Nielsen, Pernille Brok [1 ,2 ,19 ]
Kristensen, Jonas H. [1 ,2 ,19 ]
Ostergaard, Lars [11 ,20 ]
Ellermann-Eriksen, Svend [7 ,20 ]
Andersen, Berit [12 ,20 ]
Nielsen, Henrik [13 ,22 ]
Johansen, Isik S. [14 ,21 ]
Wiese, Lothar [15 ]
Simonsen, Lone [16 ]
Fischer, Thea K. [17 ,23 ]
Folke, Fredrik [18 ,19 ]
Lippert, Freddy [18 ,19 ]
Ostrowski, Sisse R. [6 ,19 ]
Ethelberg, Steen [5 ,23 ]
Koch, Anders [4 ,5 ,19 ]
Vangsted, Anne-Marie [5 ]
Krause, Tyra Grove [5 ]
Fomsgaard, Anders [5 ]
Nielsen, Claus [5 ]
Ullum, Henrik [5 ]
Skov, Robert [5 ]
Iversen, Kasper [1 ,2 ,19 ]
机构
[1] Copenhagen Univ Hosp, Dept Cardiol, Borgmester Lb Juuls Vej 1, DK-2730 Herlev, Denmark
[2] Copenhagen Univ Hosp, Dept Emergency Med, Herlev, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Copenhagen, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis, Copenhagen, Denmark
[5] Statens Serum Inst, Copenhagen, Denmark
[6] Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, Copenhagen, Denmark
[7] Aarhus Univ Hosp, Dept Clin Microbiol, Aarhus, Denmark
[8] Zealand Univ Hosp, Dept Clin Immunol, Koge, Denmark
[9] Odense Univ Hosp, Dept Clin Immunol, Odense, Denmark
[10] Aalborg Univ Hosp, Dept Clin Immunol, Aalborg, Denmark
[11] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
[12] Univ Res Clin Canc Screening, Randers Reg Hosp, Randers, Denmark
[13] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark
[14] Odense Univ Hosp, Dept Infect Dis, Odense, Denmark
[15] Zealand Univ Hosp, Dept Infect Dis, Roskilde, Denmark
[16] Roskilde Univ, Dept Sci & Environm, Roskilde, Denmark
[17] North Zealand Hosp, Dept Clin Res, Hillerod, Denmark
[18] Copenhagen Emergency Med Serv, Copenhagen, Denmark
[19] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark
[20] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[21] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[22] Aalborg Univ, Dept Clin Med, Odense, Denmark
[23] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark
关键词
SARS-CoV-2; COVID-19; Seroprevalence; Social housing areas; Antibodies;
D O I
10.1186/s12879-022-07102-1
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background COVID-19 is thought to be more prevalent among ethnic minorities and individuals with low socioeconomic status. We aimed to investigate the prevalence of SARS-CoV-2 antibodies during the COVID-19 pandemic among citizens 15 years or older in Denmark living in social housing (SH) areas. Methods We conducted a study between January 8th and January 31st, 2021 with recruitment in 13 selected SH areas. Participants were offered a point-of-care rapid SARS-CoV-2 IgM and IgG antibody test and a questionnaire concerning risk factors associated with COVID-19. As a proxy for the general Danish population we accessed data on seroprevalence from Danish blood donors (total Ig ELISA assay) in same time period. Results Of the 13,279 included participants, 2296 (17.3%) were seropositive (mean age 46.6 (SD 16.4) years, 54.2% female), which was 3 times higher than in the general Danish population (mean age 41.7 (SD 14.1) years, 48.5% female) in the same period (5.8%, risk ratios (RR) 2.96, 95% CI 2.78-3.16, p > 0.001). Seropositivity was higher among males (RR 1.1, 95% CI 1.05-1.22%, p = 0.001) and increased with age, with an OR seropositivity of 1.03 for each 10-year increase in age (95% CI 1.00-1.06, p = 0.031). Close contact with COVID-19-infected individuals was associated with a higher risk of infection, especially among household members (OR 5.0, 95% CI 4.1-6.2 p < 0,001). Living at least four people in a household significantly increased the OR of seropositivity (OR 1.3, 95% CI 1.0-1.6, p = 0.02) as did living in a multi-generational household (OR 1.3 per generation, 95% CI 1.1-1.6, p = 0.003). Only 1.6% of participants reported not following any of the national COVID-19 recommendations. Conclusions Danish citizens living in SH areas of low socioeconomic status had a three times higher SARS-CoV-2 seroprevalence compared to the general Danish population. The seroprevalence was significantly higher in males and increased slightly with age. Living in multiple generations households or in households of more than four persons was a strong risk factor for being seropositive. Results of this study can be used for future consideration of the need for preventive measures in the populations living in SH areas.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Silent SARS-CoV-2 infection: seroprevalence study of SARS-CoV-2 anti- nucleocapsid IgG antibodies in Kragujevac, Serbia
    Cicaric, Neda
    Canovic, Vanja
    Stojkovic, Milica
    Matic, Sanja
    Stefanovic, Srdjan
    Popovic, Suzana
    Todorovic, Danijela
    Djordjevic, Natasa
    Radenkovic, Biljana
    Radenkovic, Marko
    Antic, Vasilije
    Baskic, Dejan
    ACTA VIROLOGICA, 2023, 67
  • [22] Seroprevalence of SARS-CoV-2 IgG in people with cystic fibrosis
    Mahan, Kathleen
    Kiel, Sarah
    Freese, Rebecca
    Marka, Nicholas
    Dunitz, Jordan
    Billings, Joanne
    HELIYON, 2024, 10 (06)
  • [23] Nationwide retrospective mortality and seroprevalence of SARS-CoV-2 antibodies in Cameroon
    Eyong, J.
    Fai, K. N.
    Nikolay, B.
    Gignoux, E.
    Nsaibirni, R.
    Buri, D.
    Yuya, F.
    Youm, E.
    Ntone, R.
    Mbarga, N. F.
    Matchim, L.
    Tchiasso, D.
    Ngosso, A.
    Nanda, E.
    Yonta, C.
    Ndifon, M.
    Essomba, R. G.
    Wanda, F.
    Mandeng, N.
    Essaka, R.
    Koku, M. T.
    Eyangoh, S.
    Ousman, M.
    Esso, L.
    Epee, E.
    Njouom, R.
    Okom, M. C. A.
    Ciglenecki, I.
    Mballa, G. A.
    Issoufou, S.
    Porten, K.
    Boum, Y.
    SCIENTIFIC AFRICAN, 2023, 22
  • [24] Seroprevalence of SARS-CoV-2 antibodies in the county town of Slovakia - a pilot study from the Trencin city
    Kajanova, Ivana
    Grossmannova, Katarina
    Jelenska, Lenka
    Lukacikova, Lubomira
    Radikova, Zofia
    Knutova, Nikola
    Nahlikova, Jana
    Belisova, Martina
    Pastorekova, Silvia
    Kopacek, Juraj
    ACTA VIROLOGICA, 2022, 66 (03) : 228 - 237
  • [25] Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
    Capai, Lisandru
    Ayhan, Nazli
    Masse, Shirley
    Canarelli, Jean
    Priet, Stephane
    Simeoni, Marie-Helene
    Charrel, Remi
    de Lamballerie, Xavier
    Falchi, Alessandra
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 12
  • [26] Seroprevalence of SARS-CoV-2 antibodies among healthy blood donors in Karachi, Pakistan
    Younas, Amber
    Waheed, Samra
    Khawaja, Shabnum
    Imam, Mehjabeen
    Borhany, Munira
    Shamsi, Tahir
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (06)
  • [27] A community based seroprevalence of SARS-CoV-2 antibodies in Somali Region, Eastern Ethiopia
    Yared, Solomon
    Abera, Tsegalem
    Ali, Seid Mohammed
    Muhummed, Abdifatah Muktar
    Ibrahim, Mohammed
    Hassan, Abdullahi
    Hattendorf, Jan
    Zinsstag, Jakob
    Tschopp, Rea
    IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (01)
  • [28] Seroprevalence of SARS-CoV-2 antibodies in patients with hematological and oncological diseases in early 2024
    Louise M. Cremer
    Jannik Stemler
    Rosanne Sprute
    Sebastian Herrmann
    Theresa Markus
    Jon Salmanton-García
    Lutz Gieselmann
    Veronica Di Cristanziano
    Henning Gruell
    Oliver A. Cornely
    Sibylle C. Mellinghoff
    Blood Research, 2025, 60 (1)
  • [29] Estimating SARS-CoV-2 seroprevalence
    Rosin, Samuel P.
    Shook-Sa, Bonnie E.
    Cole, Stephen R.
    Hudgens, Michael G.
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-STATISTICS IN SOCIETY, 2023, 186 (04) : 834 - 851
  • [30] SARS-CoV-2 Seroprevalence at an Urban Hospital in Haiti
    Price, Robert
    Cho, Jeffrey
    Nelson, Scott
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)